CIK 0001091596
- Non-accelerated filer
- Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 233011702
- Phone
- +1 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-01-02 | CREWS DAVID Director | Grant or award · Non-qualified option to purchase common stock | +30,000 | 396,667 | ||
| 2009-01-02 | KEITH STEPHEN Director | Grant or award · Non qualified option to purchase common stock | +40,000 | 40,000 | ||
| 2009-01-02 | McLoughlin Mark T Director | Grant or award · Non qualified option to purchase common stock | +40,000 | 236,667 | ||
| 2009-01-02 | Benson James Director | Grant or award · Non-qualified option to purchase common stock | +40,000 | 230,000 | ||
| 2009-01-02 | Maslan Andrew Scott Chief Financial Officer | Purchase | +900 | $0.25 | $225 | 40,900 |
| 2009-01-02 | Maslan Andrew Scott Chief Financial Officer | Purchase | +4,300 | $0.27 | $1K | 45,200 |
| 2008-12-30 | JORDEN DAVID EMERSON Director | Purchase | +5,000 | $0.30 | $2K | 3,233,567 |
| 2008-12-29 | JORDEN DAVID EMERSON Director | Purchase | +6,200 | $0.30 | $2K | 3,228,567 |
| 2008-12-26 | JORDEN DAVID EMERSON Director | Purchase | +6,900 | $0.30 | $2K | 3,222,367 |
| 2008-12-24 | JORDEN DAVID EMERSON Director | Purchase | +16,100 | $0.30 | $5K | 3,215,467 |
| 2008-12-23 | JORDEN DAVID EMERSON Director | Purchase | +5,800 | $0.29 | $2K | 3,199,367 |
| 2008-12-16 | JORDEN DAVID EMERSON Director | Grant or award · Options to purchase Common Stock | +50,000 | 50,000 | ||
| 2008-12-16 | ROSENDALE MARTIN P Chief Executive Officer | Grant or award · Options to purchase Common Stock | +200,000 | 716,667 | ||
| 2008-12-15 | Maslan Andrew Scott Chief Financial Officer | Purchase | +4,800 | $0.38 | $2K | 40,000 |
| 2008-12-12 | Maslan Andrew Scott Chief Financial Officer | Purchase | +200 | $0.34 | $68 | 35,200 |
| 2008-12-11 | JORDEN DAVID EMERSON Director | Purchase | +9,433 | $0.30 | $3K | 3,193,567 |
| 2008-12-10 | Maslan Andrew Scott Officer | Purchase | +6,000 | $0.34 | $2K | 35,000 |
| 2008-12-09 | JORDEN DAVID EMERSON Director | Purchase | +10,000 | $0.29 | $3K | 3,184,134 |
| 2008-12-08 | JORDEN DAVID EMERSON Director | Purchase | +10,000 | $0.19 | $2K | 3,174,134 |
| 2008-09-30 | JORDEN DAVID EMERSON Director | Purchase | +10,800 | $0.68 | $7K | 3,164,134 |
Page 23 of 31 · 607 trades